{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:33:46Z","timestamp":1792794826933,"version":"4.5.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"Abstract<\/jats:title>\n \n STUDY QUESTION<\/jats:title>\n Does the freeze-all strategy in high-responders increase pregnancy rates and improve safety outcomes when compared with GnRH agonist triggering followed by low-dose hCG intensified luteal support with a fresh embryo transfer?<\/jats:p>\n <\/jats:sec>\n \n SUMMARY ANSWER<\/jats:title>\n Pregnancy rates after either fresh embryo transfer with intensified luteal phase support using low-dose hCG or the freeze-all strategy did not vary significantly; however, moderate-to-severe ovarian hyperstimulation syndrome (OHSS) occurred more frequently in the women who attempted a fresh embryo transfer.<\/jats:p>\n <\/jats:sec>\n \n WHAT IS KNOWN ALREADY<\/jats:title>\n Two strategies following GnRH agonist triggering (the freeze-all approach and a fresh embryo transfer attempt using a low-dose of hCG for intensified luteal phase support) are safer alternatives when compared with conventional hCG triggering with similar pregnancy outcomes. However, these two strategies have never been compared head-to-head in an unrestricted predicted hyper-responder population.<\/jats:p>\n <\/jats:sec>\n \n STUDY DESIGN, SIZE, DURATION<\/jats:title>\n This study included women with an excessive response to ovarian stimulation (\u226518 follicles measuring \u226511 mm) undergoing IVF\/ICSI in a GnRH antagonist suppressed cycle between 2014 and 2017. Our primary outcome was clinical pregnancy at 7 weeks after the first embryo transfer. Secondary outcomes included live birth and the development of moderate-to-severe OHSS.<\/jats:p>\n <\/jats:sec>\n \n PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n Following GnRH agonist triggering, women were randomized either to cryopreserve all good-quality embryos followed by a frozen embryo transfer in an subsequent artificial cycle or to perform a fresh embryo transfer with intensified luteal phase support (1500 IU hCG on the day of oocyte retrieval, plus oral estradiol 2 mg two times a day, plus 200 mg of micronized vaginal progesterone three times a day).<\/jats:p>\n <\/jats:sec>\n \n MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n A total of 212 patients (106 in each arm) were recruited in the study, with three patients (one in the fresh embryo transfer group and two in the freeze-all group) later withdrawing their consent to participate in the study. One patient in the freeze-all group became pregnant naturally (clinical pregnancy diagnosed 38 days after randomization) prior to the first frozen embryo transfer. The study arms did not vary significantly in terms of the number of oocytes retrieved and embryos produced\/transferred. The intention to treat clinical pregnancy and live birth rates (with the latter excluding four cases lost to follow-up: one in the fresh transfer and three in the freeze-all arms, respectively) after the first embryo transfer did not vary significantly among the fresh embryo transfer and freeze-all study arms: 51\/105 (48.6%) versus 57\/104 (54.8%) and 41\/104 (39.4%) versus 42\/101 (41.6%), respectively (relative risk for clinical pregnancy 1.13, 95% CI 0.87\u20131.47; P\u2009=\u20090.41). However, moderate-to-severe OHSS occurred solely in the group that received low-dose hCG (9\/105, 8.6%, 95% CI 3.2% to 13.9% vs 0\/104, 95% CI 0 to 3.7, P\u2009&lt;\u20090.01).<\/jats:p>\n <\/jats:sec>\n \n LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n The sample size calculation was based on a 19% absolute difference in terms of clinical pregnancy rates, therefore smaller differences, as observed in the trial, cannot be reliably excluded as non-significant.<\/jats:p>\n <\/jats:sec>\n \n WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n This study offers the first comparative analysis of two common strategies applied to women performing IVF\/ICSI with a high risk to develop OHSS. While pregnancy rates did not vary significantly, a fresh embryo transfer with intensified luteal phase support may still not avoid the risk of moderate-to-severe OHSS and serious consideration should be made before recommending it as a routine first-line treatment. Future trials may allow us to confirm these findings.<\/jats:p>\n <\/jats:sec>\n \n STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n The authors have no conflicts of interest to disclose. No external funding was obtained for this study.<\/jats:p>\n <\/jats:sec>\n \n TRIAL REGISTRATION NUMBER<\/jats:title>\n ClinicalTrials.gov identifier NCT02148393.<\/jats:p>\n <\/jats:sec>\n \n TRIAL REGISTRATION DATE<\/jats:title>\n 28 May 2014<\/jats:p>\n <\/jats:sec>\n \n DATE OF FIRST PATIENT\u2019S ENROLMENT<\/jats:title>\n 30 May 2014<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/humrep\/deaa226","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T19:26:49Z","timestamp":1597346809000},"page":"2808-2818","source":"Crossref","is-referenced-by-count":46,"title":["The freeze-all strategy versus agonist triggering with low-dose hCG for luteal phase support in IVF\/ICSI for high responders: a randomized controlled trial"],"prefix":"10.1093","volume":"35","author":[{"given":"Samuel","family":"Santos-Ribeiro","sequence":"first","affiliation":[{"name":"IVIRMA Lisboa, Avenida Infante Dom Henrique 333 H 1-9, Lisbon, Portugal"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of Lisbon, Lisboa, Portugal"},{"name":"Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Mackens","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biljana","family":"Popovic-Todorovic","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Racca","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos P","family":"Polyzos","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Medicine, Dexeus University Hospital, Barcelona, Spain"},{"name":"Department of Surgical and Clinical Science, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium"},{"name":"Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbet","family":"Van Landuyt","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Drakopoulos","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium"},{"name":"Department of Surgical and Clinical Science, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"de Vos","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Tournaye","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Blockeel","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium"},{"name":"Department of Obstetrics and Gynaecology, School of Medicine, University of Zagreb, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"2020121617434767000_deaa226-B1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.29252\/ijrm.16.1.9","article-title":"Fresh versus frozen embryo transfer after gonadotropin-releasing hormone agonist trigger in gonadotropin-releasing hormone antagonist cycles among high responder women: a randomized, multi-center study","volume":"16","author":"Aflatoonian","year":"2018","journal-title":"Int J Reprod Biomed (Yazd)"},{"key":"2020121617434767000_deaa226-B2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10815-010-9412-9","article-title":"Can fresh embryo transfers be replaced by cryopreserved-thawed embryo transfers in assisted reproductive cycles? A randomized controlled trial","volume":"27","author":"Aflatoonian","year":"2010","journal-title":"J Assist Reprod Genet"},{"key":"2020121617434767000_deaa226-B3","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s10815-013-0084-0","article-title":"Retraction note to: can fresh embryo transfers be replaced by cryopreserved-thawed embryo transfers in assisted reproductive cycles? A randomized controlled trial","volume":"30","author":"Aflatoonian","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"2020121617434767000_deaa226-B4","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"5","author":"Al-Inany","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2020121617434767000_deaa226-B5","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10815-016-0764-7","article-title":"Micro-dose hCG as luteal phase support without exogenous progesterone administration: mathematical modelling of the hCG concentration in circulation and initial clinical experience","volume":"33","author":"Andersen","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"2020121617434767000_deaa226-B6","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/humrep\/dei475","article-title":"Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial","volume":"21","author":"Babayof","year":"2006","journal-title":"Hum Reprod"},{"key":"2020121617434767000_deaa226-B7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.fertnstert.2016.04.004","article-title":"Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders","volume":"106","author":"Bar-Hava","year":"2016","journal-title":"Fertil Steril"},{"key":"2020121617434767000_deaa226-B8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.fertnstert.2018.02.003","article-title":"Luteal phase support after gonadotropin-releasing hormone agonist triggering: does it still matter?","volume":"109","author":"Benadiva","year":"2018","journal-title":"Fertil Steril"},{"key":"2020121617434767000_deaa226-B9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/humrep\/dev339","article-title":"A fresh look at the freeze-all protocol: a SWOT analysis","volume":"31","author":"Blockeel","year":"2016","journal-title":"Hum Reprod"},{"key":"2020121617434767000_deaa226-B10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/molehr\/gaq070","article-title":"Gene expression profile in the endometrium on the day of oocyte retrieval after ovarian stimulation with low-dose hCG in the follicular phase","volume":"17","author":"Blockeel","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"2020121617434767000_deaa226-B11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1513873","article-title":"Fresh versus frozen embryos for infertility in the polycystic ovary syndrome","volume":"375","author":"Chen","year":"2016","journal-title":"N Engl J Med"},{"key":"2020121617434767000_deaa226-B12","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-Free Clinic by segmentation of IVF treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Hum Reprod"},{"key":"2020121617434767000_deaa226-B13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/humupd\/dmm011","article-title":"Evian annual reproduction workshop g. the role of the endometrium and embryo in human implantation","volume":"13","author":"Diedrich","year":"2007","journal-title":"Hum Reprod Update"},{"key":"2020121617434767000_deaa226-B14","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/humrep\/dey054","article-title":"Towards an optimal luteal support modality in agonist triggered cycles: a randomized clinical trial","volume":"33","author":"Elgindy","year":"2018","journal-title":"Hum Reprod"},{"key":"2020121617434767000_deaa226-B15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","article-title":"The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertil Steril"},{"key":"2020121617434767000_deaa226-B16","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.fertnstert.2014.01.019","article-title":"Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and \u201cfreeze-all\u201d approach in GnRH antagonist protocol","volume":"101","author":"Fatemi","year":"2014","journal-title":"Fertil Steril"},{"key":"2020121617434767000_deaa226-B17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jcem.87.2.8197","article-title":"Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization","volume":"87","author":"Fauser","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020121617434767000_deaa226-B18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/09513590.2018.1548591","article-title":"Luteal phase support with GnRH agonist does not eliminate the risk for ovarian hyperstimulation syndrome","volume":"35","author":"Friedler","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"2020121617434767000_deaa226-B19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1472-6483(10)60042-9","article-title":"Symposium: Update on prediction and management of OHSS. A modern classification of OHSS","volume":"19","author":"Golan","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"2020121617434767000_deaa226-B20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/14647273.2014.998726","article-title":"To freeze or not to freeze embryos: clarity, confusion and conflict","volume":"18","author":"Goswami","year":"2015","journal-title":"Hum Fertil"},{"key":"2020121617434767000_deaa226-B21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.fertnstert.2011.11.016","article-title":"Agonist trigger: what is the best approach? Agonist trigger and low dose hCG","volume":"97","author":"Humaidan","year":"2012","journal-title":"Fertil Steril"},{"key":"2020121617434767000_deaa226-B22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.fertnstert.2008.12.042","article-title":"1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study","volume":"93","author":"Humaidan","year":"2010","journal-title":"Fertil Steril"},{"key":"2020121617434767000_deaa226-B23","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.fertnstert.2015.01.034","article-title":"Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches","volume":"103","author":"Humaidan","year":"2015","journal-title":"Fertil Steril"},{"key":"2020121617434767000_deaa226-B24","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/humrep\/det249","article-title":"GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum Reprod"},{"key":"2020121617434767000_deaa226-B25","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/humrep\/det304","article-title":"Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study","volume":"28","author":"Iliodromiti","year":"2013","journal-title":"Hum Reprod"},{"key":"2020121617434767000_deaa226-B26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1757-2215-6-93","article-title":"Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study","volume":"6","author":"Iliodromiti","year":"2013","journal-title":"J Ovarian Res"},{"key":"2020121617434767000_deaa226-B27","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.rbmo.2015.09.001","article-title":"\u2018Luteal coasting\u2019 after GnRH agonist trigger - individualized, HCG-based, progesterone-free luteal support in \u2018high responders\u2019: a case series","volume":"31","author":"Kol","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"2020121617434767000_deaa226-B28","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0015-0282(02)03323-X","article-title":"Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up","volume":"78","author":"Kolibianakis","year":"2002","journal-title":"Fertil Steril"},{"key":"2020121617434767000_deaa226-B29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.rbmo.2017.09.014","article-title":"GnRHa trigger and luteal coasting: a new approach for the ovarian hyperstimulation syndrome high-risk patient?","volume":"36","author":"Lawrenz","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"2020121617434767000_deaa226-B30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/09513590.2017.1391204","article-title":"Luteal phase serum progesterone levels after GnRH-agonist trigger - how low is still high enough for an ongoing pregnancy?","volume":"34","author":"Lawrenz","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"2020121617434767000_deaa226-B31","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/humrep\/dex285","article-title":"Frozen embryo transfer: a review on the optimal endometrial preparation and timing","volume":"32","author":"Mackens","year":"2017","journal-title":"Hum Reprod"},{"key":"2020121617434767000_deaa226-B32","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1093\/humrep\/dew263","article-title":"Frozen-thawed embryo transfers in natural cycles with spontaneous or induced ovulation: the search for the best protocol continues","volume":"31","author":"Montagut","year":"2016","journal-title":"Hum Reprod"},{"key":"2020121617434767000_deaa226-B33","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/humrep\/dep035","article-title":"Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE","volume":"24","author":"Nyboe Andersen","year":"2009","journal-title":"Hum Reprod"},{"key":"2020121617434767000_deaa226-B34","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1093\/humrep\/dei217","article-title":"Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective study","volume":"20","author":"Papanikolaou","year":"2005","journal-title":"Hum Reprod"},{"key":"2020121617434767000_deaa226-B35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fertnstert.2005.07.1292","article-title":"Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles","volume":"85","author":"Papanikolaou","year":"2006","journal-title":"Fertil Steril"},{"key":"2020121617434767000_deaa226-B36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/humupd\/dmy033","article-title":"Fresh versus elective frozen embryo transfer in IVF\/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes","volume":"25","author":"Roque","year":"2019","journal-title":"Hum Reprod Update"},{"key":"2020121617434767000_deaa226-B37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.fertnstert.2012.09.003","article-title":"Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis","volume":"99","author":"Roque","year":"2013","journal-title":"Fertil Steril"},{"key":"2020121617434767000_deaa226-B38","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"2020121617434767000_deaa226-B39","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1093\/humrep\/det124","article-title":"Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG","volume":"28","author":"Seyhan","year":"2013","journal-title":"Hum Reprod"},{"key":"2020121617434767000_deaa226-B40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.fertnstert.2011.05.050","article-title":"Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders","volume":"96","author":"Shapiro","year":"2011","journal-title":"Fertil Steril"},{"key":"2020121617434767000_deaa226-B41","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.fertnstert.2011.02.059","article-title":"Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfers in high responders","volume":"96","author":"Shapiro","year":"2011","journal-title":"Fertil Steril"},{"key":"2020121617434767000_deaa226-B42","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","article-title":"Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles","volume":"101","author":"Steward","year":"2014","journal-title":"Fertil Steril"},{"key":"2020121617434767000_deaa226-B43","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/humrep\/dez006","article-title":"Patients' attitudes and preferences towards a freeze-all strategy in ART treatment","volume":"34","author":"Stormlund","year":"2019","journal-title":"Hum Reprod"},{"key":"2020121617434767000_deaa226-B44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0015-0282(97)80080-5","article-title":"Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase","volume":"67","author":"Ubaldi","year":"1997","journal-title":"Fertil Steril"},{"key":"2020121617434767000_deaa226-B45","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/humrep\/deq374","article-title":"Outcome of closed blastocyst vitrification in relation to blastocyst quality: evaluation of 759 warming cycles in a single-embryo transfer policy","volume":"26","author":"Van Landuyt","year":"2011","journal-title":"Hum Reprod"},{"key":"2020121617434767000_deaa226-B46","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.rbmo.2019.07.031","article-title":"Repeated GnRH agonist doses for luteal support: a proof of concept","volume":"39","author":"Wiser","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"2020121617434767000_deaa226-B47","first-page":"CD008046","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology","volume":"10","author":"Youssef","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2020121617434767000_deaa226-B48","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/humrep\/dep343","article-title":"The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary on ART Terminology, 2009","volume":"24","author":"Zegers-Hochschild","year":"2009","journal-title":"Hum Reprod"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/12\/2808\/34927963\/deaa226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/12\/2808\/34927963\/deaa226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T18:25:55Z","timestamp":1608315955000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/35\/12\/2808\/5910340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,9,23]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaa226","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,9,23]]}}}